Vor Biopharma Inc.
VOR
$0.2232
-$0.0006-0.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.49M | -30.71M | -27.56M | -27.84M | -30.80M |
| Total Depreciation and Amortization | 825.00K | 865.00K | 851.00K | 869.00K | 943.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.23M | 2.97M | 3.52M | 3.72M | 3.52M |
| Change in Net Operating Assets | -2.64M | 2.82M | -99.00K | 1.41M | -4.12M |
| Cash from Operations | -31.07M | -24.06M | -23.29M | -21.85M | -30.47M |
| Capital Expenditure | -231.00K | -72.00K | -34.00K | -9.00K | -114.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 0.00 | 0.00 | 53.00M | 44.09M |
| Cash from Investing | -230.00K | -72.00K | -34.00K | 52.99M | 43.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 55.64M | 111.00K | 20.00K | 278.00K |
| Repurchase of Common Stock | -55.00K | -30.00K | -70.00K | -51.00K | -182.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -551.00K | -2.33M | -- | -- | -- |
| Cash from Financing | -606.00K | 53.29M | 41.00K | -31.00K | 96.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.90M | 29.15M | -23.28M | 31.11M | 13.60M |